UFF
RMD icon

USA Financial Formulas’s ResMed RMD Stock Holding History

USA Financial Formulas’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12K Hold
5
– – ﹤0.01% 330
2025
Q4 		$1.2K Sell
5
-2,017
-100% -$516K ﹤0.01% 294
2025
Q3 		$553K Buy
+2,022
New +$552K 0.1% 87
2021
Q1 		– Sell
-5
Closed -$1K – 413
2020
Q4 		$1K Hold
5
– – ﹤0.01% 298
2020
Q3 		$1K Hold
5
– – ﹤0.01% 290
2020
Q2 		$1K Hold
5
– – ﹤0.01% 200
2020
Q1 		$1K Sell
5
-17,859
-100% -$2.84M ﹤0.01% 188
2019
Q4 		$2.77M Buy
+17,864
New +$2.57M 1.15% 31

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

USA Financial Formulas's RMD Position: Q1 2026 in Review

USA Financial Formulas held its ResMed (RMD) position steady in Q1 2026 at 5 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #330.

USA Financial Formulas first reported a position in RMD in Q4 2019 and has held it in 8 quarters since. The position peaked at $2.77M in Q4 2019. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • USA Financial Formulas held 5 shares of ResMed worth $1.12K as of Q1 2026.
  • USA Financial Formulas left its ResMed share count unchanged in Q1 2026.
  • ResMed made up ﹤0.01% of USA Financial Formulas's portfolio in Q1 2026, its #330 holding.
  • USA Financial Formulas first reported a position in ResMed in Q4 2019 and has held it in 8 quarters since.
  • USA Financial Formulas's ResMed position peaked at $2.77M in Q4 2019.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on USA Financial Formulas's 13F filing for Q1 2026, filed 14 Apr 2026.